Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patients

Biochemical and Biophysical Research Communications

Volumn 424, Issue 2, 2012, Pages 221-227

  Kopp, Benjamin T ^a   Abdulrahman, Basant A ^b,c   Khweek, Arwa A ^b   Kumar, Surender B ^b   Akhter, Anwari ^b   Montione, Richard ^b   Tazi, Mia F ^b   Caution, Kyle ^b   McCoy, Karen ^a   Amer, Amal O ^b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Ein Helwan   (Egypt)

Author keywords

Burkholderia; CF; CGD; Corticosteroids; Cystic fibrosis; IFN ; IL 1 ; IL 10; LDH; Macrophage; MCP 1; MDM

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CENOCEPACIA INFECTION; BURKHOLDERIA INFECTION; CELL DEATH; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MICROSCOPY; MONOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; APOPTOSIS; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA INFECTIONS; CHEMOKINE CCL2; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; LYSOSOMES; MACROPHAGES; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; YOUNG ADULT;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA;

EID: 84864299407     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.066     Document Type: Article

References (31)

1. Cystic Fibrosis Foundation Patient Registry, 2009 Annual data report, Bethesda, Maryland, 2010.
2. Bondong A., Kopp B., Dreger P., Ho A. Case management in allogeneic stem cell transplantation: the Heidelberg experience. FEMS Immunol. Med. Microbiol. 2006, 37:S291-S292.
3. Armstrong D.S., Hook S.M., Jamsen K.M., Nixon G.M., Carzino R., Carlin J.B., Robertson C.F., Grimwood K. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr. Pulmonol. 2005, 40:500-510.
4. Rosenfeld M., Gibson R.L., McNamara S., Emerson J., Burns J.L., Castile R., Hiatt P., McCoy K., Wilson C.B., Inglis A., Smith A., Martin T.R., Ramsey B.W. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr. Pulmonol. 2001, 32:356-366.
5. Levy H., Murphy A., Zou F., Gerard C., Klanderman B., Schuemann B., Lazarus R., Garcia K.C., Celedon J.C., Drumm M., Dahmer M., Quasney M., Schneck K., Reske M., Knowles M.R., Pier G.B., Lange C., Weiss S.T. IL1B polymorphisms modulate cystic fibrosis lung disease. Pediatr. Pulmonol. 2009, 44:580-593.
6. LiPuma J.J., Dasen S.E., Nielson D.W., Stern R.C., Stull T.L. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990, 336:1094-1096.
7. De Soyza A., Ellis C.D., Khan C.M., Corris P.A., Demarco de Hormaeche R. Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am. J. Respir. Crit. Care Med. 2004, 170:70-77.
8. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 1984, 104:206-210.
9. Jones A.M., Dodd M.E., Govan J.R., Barcus V., Doherty C.J., Morris J., Webb A.K. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 2004, 59:948-951.
10. Olland A., Falcoz P.E., Kessler R., Massard G. Should cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation?. Interact. Cardiovasc. Thorac. Surg. 2011.
11. De Soyza A., Meachery G., Hester K.L., Nicholson A., Parry G., Tocewicz K., Pillay T., Clark S., Lordan J.L., Schueler S., Fisher A.J., Dark J.H., Gould F.K., Corris P.A. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. J. Heart Lung Transplant. 2010, 29:1395-1404.
12. van de Veerdonk F.L., Smeekens S.P., Joosten L.A., Kullberg B.J., Dinarello C.A., van der Meer J.W., Netea M.G. Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc. Natl. Acad. Sci. USA 2010, 107:3030-3033.
13. Kotrange S., Kopp B., Akhter A., Abdelaziz D., Abu Khweek A., Caution K., Abdulrahman B., Wewers M.D., Mccoy K., Marsh C., Loutet S.A., Ortega X., Valvano M.A., Amer A.O. Burkholderia cenocepacia O polysaccharide chain contributes to caspase-1-dependent IL-1 beta production in macrophages. J. Leukocyte Biol. 2011, 89:481-488.
14. Ranganathan S.C., Parsons F., Gangell C., Brennan S., Stick S.M., Sly P.D. Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis. Thorax 2011, 66:408-413.
15. McKeon S., McClean S., Callaghan M. Macrophage responses to CF pathogens: JNK MAP kinase signaling by Burkholderia cepacia complex lipopolysaccharide. FEMS Immunol. Med. Microbiol. 2010, 60:36-43.
16. Holden M.T., Seth-Smith H.M., Crossman L.C., Sebaihia M., Bentley S.D., Cerdeno-Tarraga A.M., Thomson N.R., Bason N., Quail M.A., Sharp S., Cherevach I., Churcher C., Goodhead I., Hauser H., Holroyd N., Mungall K., Scott P., Walker D., White B., Rose H., Iversen P., Mil-Homens D., Rocha E.P., Fialho A.M., Baldwin A., Dowson C., Barrell B.G., Govan J.R., Vandamme P., Hart C.A., Mahenthiralingam E., Parkhill J. The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J. Bacteriol. 2009, 191:261-277.
17. Govan J.R., Brown P.H., Maddison J., Doherty C.J., Nelson J.W., Dodd M., Greening A.P., Webb A.K. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993, 342:15-19.
18. Akhter A., Gavrilin M.A., Frantz L., Washington S., Ditty C., Limoli D., Day C., Sarkar A., Newland C., Butchar J., Marsh C.B., Wewers M.D., Tridandapani S., Kanneganti T.D., Amer A.O. Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection. PLoS Pathog. 2009, 5:e1000361.
19. Kotrange S., Kopp B., Akhter A., Abdelaziz D., Abu Khweek A., Caution K., Abdulrahman B., Wewers M.D., McCoy K., Marsh C., Loutet S.A., Ortega X., Valvano M.A., Amer A.O. Burkholderia cenocepacia O polysaccharide chain contributes to caspase-1-dependent IL-1{beta} production in macrophages. J. Leukoc. Biol. 2010.
20. Abdulrahman B.A., Khweek A.A., Akhter A., Caution K., Kotrange S., Abdelaziz D.H., Newland C., Roberto Rosales-Reyes R., Kopp B., McCoy K., Montione R., Schlesinger L.S., Gavrilin M.A., Wewers M.D., Valvano M.A., Amer A. Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis. Autophagy 2011, 7.
21. Kazachkov M., Lager J., LiPuma J., Barker P.M. Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids. Pediatr. Pulmonol. 2001, 32:338-340.
22. Lamothe J., Valvano M.A. Burkholderia cenocepacia-induced delay of acidification and phagolysosomal fusion in cystic fibrosis transmembrane conductance regulator (CFTR)-defective macrophages. Microbiology 2008, 154:3825-3834.
23. Saldias M.S., Ortega X., Valvano M.A. Burkholderia cenocepacia O antigen lipopolysaccharide prevents phagocytosis by macrophages and adhesion to epithelial cells. J. Med. Microbiol. 2009, 58:1542-1548.
24. Keith K.E., Hynes D.W., Sholdice J.E., Valvano M.A. Delayed association of the NADPH oxidase complex with macrophage vacuoles containing the opportunistic pathogen Burkholderia cenocepacia. Microbiology 2009, 155:1004-1015.
25. Pillarisetti N., Williamson E., Linnane B., Skoric B., Robertson C.F., Robinson P., Massie J., Hall G.L., Sly P., Stick S., Ranganathan S. Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2011, 184:75-81.
26. Bonfield T.L., Panuska J.R., Konstan M.W., Hilliard K.A., Hilliard J.B., Ghnaim H., Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am. J. Respir. Crit. Care Med. 1995, 152:2111-2118.
27. Kuemmerle-Deschner J.B., Ramos E., Blank N., Roesler J., Felix S.D., Jung T., Stricker K., Chakraborty A., Tannenbaum S., Wright A.M., Rordorf C. Canakinumab (ACZ885, a fully human IgG1 anti-IL-1beta mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS). Arthritis Res. Ther. 2011, 13:R34.
28. Fernandez-Boyanapalli R., McPhillips K.A., Frasch S.C., Janssen W.J., Dinauer M.C., Riches D.W., Henson P.M., Byrne A., Bratton D.L. Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-gamma in a nitric oxide-dependent manner. J. Immunol. 2010, 185:4030-4041.
29. Goodyear A., Jones A., Troyer R., Bielefeldt-Ohmann H., Dow S. Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection. J. Immunol. 2010, 184:1445-1454.
30. Bonfield T.L., Konstan M.W., Burfeind P., Panuska J.R., Hilliard J.B., Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 1995, 13:257-261.
31. Abe R., Hirasawa H., Oda S., Sadahiro T., Nakamura M., Watanabe E., Nakada T.A., Hatano M., Tokuhisa T. Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. J. Surg. Res. 2008, 147:1-8.